
Turn Therapeutics Inc.
Turn Therapeutics Inc. (TTRX)
WebsitePrice
Market cap
Next catalystExpected Q4 2026GX-03 — adaptive Phase 2a/2b atopic dermatitis study · Study completionSEC filing ↗
Cash
Chart & Events
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
PreINDP1P3FilingApproved
PreINDP1P2FilingApproved